Business Wire

Momcozy Debuts in the European Market at the Baby Show


Momcozy (“the Company”), a leading maternity and baby brand with a focus on moms’ needs, attended the Baby Show with Lidl GB (“the Baby Show”), hosted at ExCel London March 3-5, 2023. The Baby Show is one of the largest pregnancy, baby, and parenting events in the UK, and has been helping new and expectant parents find everything they need for their growing families since 2002. With several stops around the UK planned for the year, the Baby Show in London allowed Momcozy to introduce themselves to the European market, which they have recently entered, and promote their products made for babies and mothers.

This press release features multimedia. View the full release here:

To view this piece of content from, please give your consent at the top of this page.

Momcozy Debuts in the European Market at the Baby Show (Photo: Business Wire)

As part of their introduction to British consumers, Momcozy showed off an assortment of pumps, pump accessories, pumping bra and other maternity-inspired products to the delight of parents. Along with handing out free milk storage bags and showcasing cutting-edge products like their Warming and Vibration Lactation Massager, Momcozy centred their stand at M61 around their most popular innovation, the S12 Pro Breast Pump.

“Our goal as a company has always been to support mothers in their parenting journey. So whether it’s a wearable breast pump, or a pumping bra all recognizes mom’s voices, as the product’s development came about from their input,” said Ella, Marketing Manager of Momcozy.

Momcozy 4-in-1 pumping bra has been a game-changer for breastfeeding moms since its launch in 2022, with several moms on Amazon praising the bra's versatility and security with different kinds of pumps, as well as its comfortable and supportive fit. According to customer feedback, the bra’s design is a particularly good fit with Momcozy’s wearable breast pumps, fitting snugly without too much pressure for a better lactation experience.

Another flagship product of Momcozy, the S12 Pro, also attracted a lot of attention at the Baby Show. Following detailed interviews with the Momcozy community, the Company developed this new, hands-free pump series with an eye toward comfort for moms. Boasting single or double pump options, the S12 Pro comes with an updated double-sealed flange design that fits more snugly to offer moms a more efficient, soft suction pumping experience that also helps them avoid leakage.

“Also, we recently announced the year-long ‘Parachute Care Program’ to support more moms' breastfeeding journeys, and hope that we will be a companion for more moms in Europe,” Ella said.

In addition to the Program, Momcozy is offering a 25% off for breast pump orders to moms who work in specific professions to celebrate International Women’s Day. Moms in Europe can shop through Amazon or Momcozy website.

Following their introduction to the UK and other European countries at the Baby Show in London, Momcozy will also participate at the event’s stop at NEC Birmingham May 12-14, 2023.

To view this piece of content from, please give your consent at the top of this page.

Contact information

Marketing Dept.
Ella Zheng
1-855-322-1777 (Mon.-Fri. 8:30am-12:00pm; 1:00pm-5:30pm PST)

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SimCorp Unites with FlexTrade to Add New EMS Ecosystem Partner28.3.2023 09:02:00 CEST | Press release

SimCorp, an independent provider of investment management solutions, has partnered with FlexTrade Systems, a global leader in high-performance multi-asset trade execution management systems (EMS), to extend SimCorp's Order Management System (OMS) capabilities by incorporating the cross-asset EMS functionality of FlexTrade's FlexTRADER EMS. This partnership addresses the increasing demand from trading teams for seamless integration and collaborative workflows between their OMS and EMS solutions. The integration will help optimize trading activities and assist in meeting best execution obligations. As part of the partnership, FlexTrade will join SimCorp's Open Platform program. The Open Platform program is designed to offer its client base frictionless access to innovative fintech solutions across the investment value chain. A key component of the new agreement will see the two firms work together to deliver enhanced, seamless connectivity between SimCorp's OMS, Order Manager, and FlexTr

euNetworks Forms Exclusive Partnership on CrossChannel Fibre System to Deliver Ultra-Low Latency Services Between London and Madrid28.3.2023 09:00:00 CEST | Press release

euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, today announced that it has entered into an exclusive partnership agreement with Crosslake Fibre UK Limited (“Crosslake”), an international network provider and developer of unique subsea and terrestrial fibre networks. This partnership relates to Crosslake’s new CrossChannel Fibre system and gives euNetworks exclusivity to deliver ultra-low latency services between the United Kingdom and Madrid on this system to the financial services community. euNetworks has also agreed to a strategic relationship, enabling the sale of dark fibre services by euNetworks using the system. This press release features multimedia. View the full release here: Paula Cogan, CEO of euNetworks (Photo: Business Wire) CrossChannel Fibre is a 550km cable system with end-to-end fibre running between Slough, United Kingdom and Paris, France and is the first subsea

Adva Network Security protects TransnetBW’s communication network28.3.2023 09:00:00 CEST | Press release

Adva Network Security today announced that TransnetBW has deployed its ConnectGuard™ encryption technology with the Adtran FSP 3000 optical transport solution to establish a highly secure communication network in its service area. As the operator of an electricity transmission grid in southwestern Germany and a European interconnection partner, TransnetBW depends on the security and reliability of its communication network to ensure trouble-free operations. That’s why the company chose the FSP 3000 optical platform with Adva Network Security encryption technology, which has been approved by the German Federal Office for Information Security (BSI). This solution enables high-speed connections to be reliably and robustly protected, even against sophisticated cyberattacks. Planning and implementation of the highly secure infrastructure were carried out by Adva Network Security’s long-standing partner Syserso Networks, who will also provide ongoing support. This press release features mult

Fujirebio expands its assay menu in the field of neurodegenerative diseases with the launch of the fully automated Lumipulse ® G NfL CSF and Lumipulse ® G NfL Blood tests28.3.2023 07:00:00 CEST | Press release

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE® G immunoassay systems. These CLEIA (chemiluminescent enzyme immunoassay) assays allow for the quantitative measurement of Neurofilament light (NfL) in human Cerebrospinal fluid (CSF) and plasma/serum, respectively, within just 35 minutes. The two assays are available for Research Use Only. “In 2022, we introduced three fully automated blood-based assays for the detection of pTau181, β-Amyloid1-42 and β-Amyloid1-40, and we are now proud to once again expand our neurodegenerative disease portfolio with the highly anticipated NfL biomarker,” Christiaan De Wilde, CEO of Fujirebio Europe and Global Head Neuro Business. “The assay menu offered by other industry leaders today is still limited and we are working diligently to create a solid lineup of tests for the entire neurodegenerative

Sofinnova Partners Launches Digital Medicine Strategy28.3.2023 06:00:00 CEST | Press release

Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced today that it has launched a new investment strategy focused on digital medicine. The strategy will be headed by Partners Edward Kliphuis and Simon Turner, who bring over a decade of experience investing in startups at the intersection of biology, data, and computation. This press release features multimedia. View the full release here: Edward Kliphuis (left) and Simon Turner (right) (Photo: Business Wire) Sofinnova Digital Medicine will back entrepreneurs innovating at the cutting edge of technology and biology and help them scale to become global leaders. Like all the funds on Sofinnova’s platform, Sofinnova Digital Medicine will focus on developing the most promising innovations that address systemic challenges in healthcare and can profoundly improve the lives of patients worldwide. Antoine Pap